TLS Online TPP Program

#Id: 1665

#Unit 4. Cell Communication and Cell Signaling

Clinical trials

Phase I clinical trials assess human safety; a small number of volunteers are monitored closely for adverse side effects.

TLS Online TPP Program

#Id: 1666

#Unit 4. Cell Communication and Cell Signaling

Phase II where effectiveness against the pathogen in question is evaluated.

TLS Online TPP Program

#Id: 1667

#Unit 4. Cell Communication and Cell Signaling

Phase III clinical trials are run in expanded volunteer populations.

TLS Online TPP Program

#Id: 1668

#Unit 4. Cell Communication and Cell Signaling

Live, Attenuated Vaccines Microorganisms can be attenuated or disabled so that they lose their ability to cause significant disease but retain their capacity for transient growth within an inoculated host.

TLS Online TPP Program

#Id: 1669

#Unit 4. Cell Communication and Cell Signaling

Live attenuated- Measles, Polio (Sabin vaccine), Mumps, Rubella,  Tuberculosis,  and Rotavirus

TLS Online TPP Program

#Id: 1670

#Unit 4. Cell Communication and Cell Signaling

Inactivated or “Killed” Vaccines This kills the pathogen, making it incapable of replication